In addition, as none of the current antidiabetic drugs can prevent or stop the reduction of BCM, for many patients, insulin injection with prefilled pens will become the only therapeutic option, like in T1D, with the problems of adherence as discussed above. The gene discussed is INS; the disease is type 1 diabetes mellitus.